Evidence map›Paper›PMID 40282929›Full record

ArticleMedicina (Kaunas, Lithuania)2025

Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study.

Ziya Kalkan, Senar Ebinc, Murat Arcagok, Ahmet Bilici, Ozcan Yildiz, Saadettin Kilickap, Deniz Can Guven, Ali Murat Tatli, Ahmet Taner Sumbul, Nil Molinas Mandel and 4 more

Erratum issuedAbstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Ziya KalkanDepartment of Medical Oncology, Mardin Training and Research Hospital, Mardin 47100, Türkiye.ORCID 0000-0001-7858-8180
Senar EbincDepartment of Medical Oncology, Van Yuzuncu Yil University Faculty of Medicine, Van 65100, Türkiye.
Murat ArcagokDepartment of Medical Oncology, Dicle University Faculty of Medicine, Diyarbakir 21100, Türkiye.ORCID 0000-0002-4058-6929
Ahmet BiliciDepartment of Medical Oncology, Faculty of Medicine, Medipol University, Istanbul 34000, Türkiye.ORCID 0000-0002-0443-6966
Ozcan YildizDepartment of Medical Oncology, Faculty of Medicine, Medipol University, Istanbul 34000, Türkiye.
Saadettin KilickapDepartment of Medical Oncology, Istinye University Faculty of Medicine, Istanbul 34000, Türkiye.
Deniz Can GuvenDepartment of Medical Oncology, Hacettepe University Cancer Institute, Ankara 06000, Türkiye.ORCID 0000-0002-6924-9467
Ali Murat TatliDepartment of Medical Oncology, Akdeniz University Faculty of Medicine, Antalya 07000, Türkiye.
Ahmet Taner SumbulDepartment of Medical Oncology, Baskent University Adana Dr. Turgut Noyan Application and Research Center, Adana 01100, Türkiye.
Nil Molinas MandelDepartment of Medical Oncology, American Hospital, Istanbul 34000, Türkiye.ORCID 0000-0002-8837-0756
Akin OzturkDepartment of Medical Oncology, Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital, Istanbul 34000, Türkiye.
Murat BardakciDepartment of Medical Oncology, Gazi Yasargil Training and Research Hospital, Diyarbakir 21100, Türkiye.ORCID 0000-0001-7854-097X
Serdar KarakayaDepartment of Medical Oncology, Ankara Ataturk Sanatoryum Training and Research Hospital, Ankara 06000, Türkiye.ORCID 0000-0002-2111-7131
Muhammet Ali KaplanDepartment of Medical Oncology, Dicle University Faculty of Medicine, Diyarbakir 21100, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ImmunotherapyMesotheliomaPleural NeoplasmsAdultAgedFemaleHumansMaleMesothelioma, MalignantMiddle AgedProgression-Free SurvivalRetrospective StudiesTreatment OutcomeTurkeyimmunotherapypleural mesotheliomareal-world data

Identifiers

PMID40282929
PMCPMC12029106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.